Hospitalization Costs of Primary Stenting Versus Thrombolysis in Acute Myocardial Infarction: Cost Analysis of the Canadian STAT Study

Background—We previously showed that primary stenting was more effective than accelerated tPA in reducing the 6-month composite of death, reinfarction, stroke, or repeat revascularization for ischemia. This study looks at the hospitalization costs of primary stenting compared with accelerated tPA. Methods and Results—Initial and 6-month hospitalization costs were computed for all patients randomly assigned to primary stenting (n=62) or accelerated tPA (n=61) in the Stenting versus Thrombolysis in Acute myocardial infarction Trial (STAT). Costs and resource usage were collected in detail for each patient. Physician fees were obtained directly from billings to the Ontario Health Insurance Plan. The length of initial hospitalization was 6.7±11.3 days in the stent group and 8.7±6.7 days in the tPA group (P <0.001). Total hospitalization days at 6 months were 8.3±13 days in the stent group and 12.1±14.0 days in the tPA group (P =0.001). Hospitalization costs were less in the stent group for the initial hospitalization, $6354±6382 versus $7893±4429 (P =0.001), and at 6 months, $7100±7111 versus $9559±6933 (P =0.001). Conclusions—In centers in which facilities and experienced interventionists are available, primary stenting is less costly and more effective than thrombolysis.

[1]  J. Boura,et al.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials , 2022 .

[2]  B J O'Brien,et al.  Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods , 2002, Statistical methods in medical research.

[3]  G. Stone,et al.  Cost-effectiveness of coronary stenting and abciximab for patients with AMI: Results from the CADILLAC trial , 2002 .

[4]  P. Touboul,et al.  Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study , 2002, The Lancet.

[5]  Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. , 2002, JAMA.

[6]  J. J. Griffin,et al.  Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. , 2002, The New England journal of medicine.

[7]  G. Stone,et al.  Cost-Effectiveness of Coronary Stenting in Acute Myocardial Infarction: Results From the Stent Primary Angioplasty in Myocardial Infarction (Stent-PAMI) Trial , 2001, Circulation.

[8]  G. Nichol,et al.  Stenting versus thrombolysis in acute myocardial infarction trial (STAT). , 2001, Journal of the American College of Cardiology.

[9]  J. Ottervanger,et al.  Long-term benefit of primary angioplasty compared to thrombolytic therapy for acute myocardial infarction. , 2000, European heart journal.

[10]  H. Suryapranata,et al.  Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. , 2000, European heart journal.

[11]  G. Stone,et al.  Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. , 2000, The New England journal of medicine.

[12]  Bruce R. Brodie,et al.  Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction , 1999 .

[13]  J. López-Sendón,et al.  Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction. , 1999, Journal of the American College of Cardiology.

[14]  H. Suryapranata,et al.  Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. , 1998, Circulation.

[15]  M. Simoons,et al.  A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. , 1997, The New England journal of medicine.

[16]  J. O’Keefe,et al.  Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators. , 1997, Journal of the American College of Cardiology.

[17]  H. Suryapranata,et al.  A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction. , 1995, The American journal of cardiology.

[18]  D. Massel,et al.  Management of the postmyocardial infarction patient: a consensus report--revision of 1991 CCS guidelines. , 1995, The Canadian journal of cardiology.

[19]  Erry,et al.  Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. , 1995, The New England journal of medicine.

[20]  P. Kligfield Primary angioplasty in myocardial infarction. , 1995, British heart journal.

[21]  K. Lee,et al.  Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group. , 1994, Journal of the American College of Cardiology.

[22]  J. Reiber,et al.  A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. , 1993, The New England journal of medicine.

[23]  K. Bailey,et al.  Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. , 1993, The New England journal of medicine.

[24]  J O'Keefe,et al.  A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction , 1993 .

[25]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[26]  S. Finkler The distinction between cost and charges. , 1982, Annals of internal medicine.